Schmidt, Timothy M. http://orcid.org/0000-0002-5860-2640
Fonseca, Rafael http://orcid.org/0000-0002-5938-3769
Usmani, Saad Z. http://orcid.org/0000-0002-5484-8731
Article History
Received: 10 January 2021
Revised: 15 March 2021
Accepted: 29 March 2021
First Online: 29 April 2021
Conflict of interest
: T.M.S. declares no conflict of interest. R.F. served as a consultant for AbbVie, Aduro, Amgen, Bayer, BMS/Celgene, GlaxoSmithKline, Janssen, Juno, Kite, Merck, Novartis, OncoTracker, Pharmacyclics, Sanofi, and Takeda; and participated in an advisory board for Adaptive Biotechnologies, Caris Live Sciences, and OncoTracker. S.Z.U. served as a consultant/advisor for Amgen, Bristol-Myers Squibb, Celgene, Janssen, Merck, SkylineDx, and Takeda; participated in a Speakers Bureau for Amgen, Celgene, Janssen, Sanofi, and Takeda; and received research grants from Amgen, Array Biopharma, Bristol-Myers Squibb, Celgene, Janssen, Merck, Pharmacyclics, Sanofi, and Takeda.